Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
Cohort I
DRUG
3 trials
Sponsors
Genentech, Inc.
, American Regent, Inc.
, Weill Medical College of Cornell University
Conditions
Asthma
COPD
Healthy
Restless Legs Syndrome
Smoking
Phase 2
Iron Sucrose In The Treatment of Restless Legs Syndrome: Safety of Three Dose Regimens as Evaluated by Clinical Assessments
Completed
NCT00895232
American Regent, Inc.
Restless Legs Syndrome
Start: 2003-11-30
End: 2005-11-30
Updated: 2024-11-07
Phase 4
The Safety and Utility of Skin Testing With XOLAIR® (Omalizumab) and Placebo Omalizumab (Formulation Excipients)
Completed
NCT00777764
Genentech, Inc.
Asthma, Healthy
Start: 2008-08-31
End: 2009-04-30
Updated: 2017-06-14
Unknown Phase
COPD Metabolome, Smoking Oxidants and Aberrant Ciliated Cell Function
Terminated
NCT01974154
Weill Medical College of Cornell University
COPD, Smoking
Start: 2013-12-31
End: 2019-05-31
Updated: 2020-07-30